Evolutionary classification of CRISPR–Cas systems

a burst of class 2 and derived variants

Review (2019)
Author(s)

Kira S. Makarova (National Library of Medicine)

Yuri I. Wolf (National Library of Medicine)

Jaime Iranzo (National Library of Medicine)

Sergey A. Shmakov (National Library of Medicine)

Omer S. Alkhnbashi (University of Freiburg)

Stan J.J. Brouns (TU Delft - BN/Stan Brouns Lab, Kavli institute of nanoscience Delft)

Emmanuelle Charpentier (Humboldt-Universitat zu Berlin)

David Cheng (Arbor Biotechnologies, Cambridge)

Shiraz A. Shah (University of Copenhagen)

undefined More Authors (External organisation)

Research Group
BN/Stan Brouns Lab
DOI related publication
https://doi.org/10.1038/s41579-019-0299-x Final published version
More Info
expand_more
Publication Year
2019
Language
English
Research Group
BN/Stan Brouns Lab
Journal title
Nature Reviews Microbiology
Issue number
2
Volume number
18
Pages (from-to)
67-83
Downloads counter
419

Abstract

The number and diversity of known CRISPR–Cas systems have substantially increased in recent years. Here, we provide an updated evolutionary classification of CRISPR–Cas systems and cas genes, with an emphasis on the major developments that have occurred since the publication of the latest classification, in 2015. The new classification includes 2 classes, 6 types and 33 subtypes, compared with 5 types and 16 subtypes in 2015. A key development is the ongoing discovery of multiple, novel class 2 CRISPR–Cas systems, which now include 3 types and 17 subtypes. A second major novelty is the discovery of numerous derived CRISPR–Cas variants, often associated with mobile genetic elements that lack the nucleases required for interference. Some of these variants are involved in RNA-guided transposition, whereas others are predicted to perform functions distinct from adaptive immunity that remain to be characterized experimentally. The third highlight is the discovery of numerous families of ancillary CRISPR-linked genes, often implicated in signal transduction. Together, these findings substantially clarify the functional diversity and evolutionary history of CRISPR–Cas.